Takeda Pharmaceutical Co Ltd (TAK)
13.28
-0.14
(-1.01%)
USD |
NYSE |
Dec 16, 16:00
13.28
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Total Liabilities (Quarterly): 53.58B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| HUTCHMED (China) Ltd | 508.85M |
| Astellas Pharma Inc | 13.04B |
| Nxera Pharma Co Ltd | 543.75M |
| PeptiDream Inc | 230.61M |
| Healios KK | 90.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 102.04B |
| Shareholders Equity (Quarterly) | 48.46B |
| Debt to Equity Ratio | 0.7299 |
| Current Ratio | 1.279 |
| Net Debt Paydown Yield | -1.15% |